APPLIED GENETIC TECHNOLOGIES CORP Deferred Revenue
APPLIED GENETIC TECHNOLOGIES CORP had Deferred Revenue of $149.00 million as of 2022-09-30, per its 10-Q filed 2022-11-21.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenue · last filed 2022-11-21
- 2022-09-30: Deferred Revenue $149.00M.
- 2022-06-30: Deferred Revenue $149.00M; Deferred Revenue as first filed $149.00K.
- 2022-03-31: Deferred Revenue $449.00K.
- 2021-12-31: Deferred Revenue $449.00K.
| Period end | Deferred Revenue | Deferred Revenue as first filed |
|---|---|---|
| 2022-09-30 | $149.00M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | $149.00M 10-Q · filed 2022-11-21 | $149.00K 10-K · filed 2022-09-27 |
| 2022-03-31 | $449.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $449.00K 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $374.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $374.00K 10-K · filed 2022-09-27 | |
| 2021-03-31 | $374.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $149.00K 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $149.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $149.00K 10-K · filed 2021-09-23 | |
| 2017-06-30 | $25.40M 10-K · filed 2017-09-13 | |
| 2017-03-31 | $24.82M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $36.03M 10-Q · filed 2017-02-08 | |
| 2016-09-30 | $43.73M 10-Q · filed 2016-11-08 | |
| 2016-06-30 | $46.90M 10-K/A · filed 2017-09-08 | |
| 2016-03-31 | $46.90M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $46.90M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $46.90M 10-Q · filed 2015-11-05 | |
| 2013-06-30 | $212.00K 10-K · filed 2014-09-26 |